Title: "Chinese Chemical Companies Indicted for Selling Cutting Agents to Fentanyl Dealers in the U.S.
A federal grand jury in Dayton has indicted four Chinese chemical companies and 25 individuals for allegedly selling cutting agents to fentanyl dealers in the United States in exchange for cryptocurrency. The U.S. Attorney's Office for the Southern District of Ohio claims that since 2022, the defendants promoted cutting agents on online platforms, negotiated sales, collected payments in cryptocurrencies, and arranged shipments to domestic buyers. The cutting agents mentioned in the indictment include animal tranquilizers xylazine and medetomidine, as well as synthetic opioids metonitazene and protonitazene.
These cutting agents were sold to dealers in the U.S. to enhance the yield and potency of fentanyl. According to the indictment, one kilogram of medetomidine can transform a kilogram of fentanyl and inert cut into multiple kilograms of fentanyl mixture for street-level sales. Eric Michael Payne, an alleged dealer, is accused of contacting one of the companies to purchase cutting agents, paying $70,000 in cryptocurrency for the chemicals, mixing them with fentanyl, and reselling the resulting mixture to other dealers. Payne was arrested recently and is being held pending trial.
The indictment also mentions the involvement of Guangzhou Wanjiang Biotechnology and other Chinese companies in similar crimes. Prosecutors in Florida targeted Guangzhou Tengyue Chemical and seven other Chinese companies for comparable offenses last year. The illegal sale of cutting agents to fentanyl dealers poses a significant threat to public health and safety, as these substances are used to increase the potency of dangerous drugs. It is crucial for law enforcement agencies to continue investigating and prosecuting individuals and companies involved in such illicit activities to protect communities from the harmful effects of drug trafficking.